Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08SKX
|
||||
| Drug Name |
recAAT, PPL Therapeutics/Bayer
|
||||
| Synonyms |
AAT therapy, PPLTherapeutics/Bayer; alpha-1 antitrypsin, PPL Therapeutics/Bayer; rAAT, PPL; recAAT, PPL Therapeutics/Bayer
|
||||
| Indication | Unspecified | Investigative | [1] | ||
| Target and Pathway | |||||
| Target(s) | Trypsin | Target Info | Modulator | ||
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| Pancreatic secretion | |||||
| Protein digestion and absorption | |||||
| Influenza A | |||||
| Reactome | Activation of Matrix Metalloproteinases | ||||
| Cobalamin (Cbl, vitamin B12) transport and metabolism | |||||
| WikiPathways | Activation of Matrix Metalloproteinases | ||||
| References | |||||
| REF 1 | Reduction in neutrophil elastase concentration by recombinant alphal-antitrypsin (recAAT) does not alter bacterial loading in the sputum of cystic fibrosis patients. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.